<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163178">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01969396</url>
  </required_header>
  <id_info>
    <org_study_id>12-012</org_study_id>
    <nct_id>NCT01969396</nct_id>
  </id_info>
  <brief_title>Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology</brief_title>
  <official_title>Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the adequacy of an endometrial biopsy sample obtained using sonohysterography.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>percentage of adequate endometrial biopsies utilizing sonohysterography</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>percentage of adequate endometrial biopsies collected without sonohysterography</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Menorrhagia</condition>
  <condition>Endometrial Neoplasms</condition>
  <condition>Polycystic Ovary Syndrome</condition>
  <condition>Uterine Neoplasms</condition>
  <arm_group>
    <arm_group_label>SonoBiopsy Catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Endometrial biopsy catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SonoBiopsy Catheter</intervention_name>
    <description>Catheter utilized in dual role: sonohysterography and endometrial biopsy</description>
    <arm_group_label>SonoBiopsy Catheter</arm_group_label>
    <other_name>Endometrial biopsy with sonohysterography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endometrial biopsy catheter</intervention_name>
    <description>Endometrial sample obtained without the assistance of sonohysterography</description>
    <arm_group_label>Endometrial biopsy catheter</arm_group_label>
    <other_name>Endometrial biopsy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with thickened endometrium

          -  Abnormal uterine bleeding

        Exclusion Criteria:

          -  Pregnant

          -  Active pelvic infection

          -  Pelvic inflammatory disease

          -  Blood clotting disorders

          -  Sexually transmitted disease

          -  Uterine perforation

          -  Recent cesarean section
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Mastellari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Punta Pacifica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Teresa Woolard</last_name>
    <phone>765-463-7537</phone>
    <email>twoolard@medinst.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Punta Pacifica</name>
      <address>
        <city>Panama City</city>
        <zip>8C6Q1 JGW8N</zip>
        <country>Panama</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Pretto, MD</last_name>
      <phone>507-204-8001</phone>
      <email>IRB@HPP.COM.PA</email>
    </contact>
  </location>
  <location_countries>
    <country>Panama</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 30, 2014</lastchanged_date>
  <firstreceived_date>October 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biopsy</keyword>
  <keyword>Endometrial biopsy</keyword>
  <keyword>Endometrial sampling</keyword>
  <keyword>sonohysterography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Endometrial Neoplasms</mesh_term>
    <mesh_term>Menorrhagia</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Uterine Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
